Digital Health in the EU: What are the new rules and reimbursement challenges?

Paris-based partner Alexandre Regniault discusses the regulatory situation and funding structures of digital health products with Medtech Insight.

This article was first published by Medtech Insight on 03 November 2017 who have agreed to Simmons & Simmons making it available on elexica.

Digital health products are struggling gain traction in the EU in part due to an undefined regulatory situation and lack of funding structures. Now the scene is complicated by new EU regulations in medtech. Digital health products are struggling gain traction in the EU in part due to an undefined regulatory situation and lack of funding structures. Now the scene is complicated by new EU regulations in medtech. What should companies do? Read the full article.

Read the full article here

This document (and any information accessed through links in this document) is provided for information purposes only and does not constitute legal advice. Professional legal advice should be obtained before taking or refraining from any action as a result of the contents of this document.